Mindfulness Mediation Intervention in Chronic Obstructive Pulmonary Disease (COPD)
Study Details
Study Description
Brief Summary
The purpose of this study is to assess the feasibility and potential impact of an eight week program of meditation on expiratory time, anxiety and dyspnea in people with COPD.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Chronic Obstructive Pulmonary Disease is a progressive multi-dimensional disease with a complex network of somatic and affective components. Anxiety is a common experience for persons with COPD both as a reaction to dyspnea (48) and as a separate co-morbid condition (10, 26). The presence of anxiety magnifies COPD symptoms and further impairs physical functioning (53). Both anxiety and COPD alter breathing patterns similarly causing irregular rapid shallow breathing at rest, which is inefficient and cannot adequately respond to increases in ventilatory demands from physical or emotional activity (121). Both COPD and anxiety are also associated with changes in neurological functioning. Whereas anxiety tends to be associated with increased amygdala activity (54), COPD is associated with a decrease in frontal cortex functioning (25, 28, 122). Persons with COPD who experience anxiety are less able to correctly process the level of physical and emotional demand for any given situation and their ability to meet that demand (46, 123). Pulmonary rehabilitation addresses both the physical and emotional symptoms of COPD, however gains in function are quickly lost over time (4). Evidence suggests that mindfulness based meditation can alter neural pathways to facilitate processing of emotions and increase quality of life for persons with COPD. The overall objective of this study is to assess the ability of persons with COPD to participate in a mindfulness meditation intervention and to examine the impact of mindfulness meditation on their anxiety levels and global sense of coherence. A modified version of Antonovsky's sense of coherence model will be used as the framework for this study. We will address the specific aims: 1) to determine the effects of mindfulness meditation on breathing patterns; 2) To determine the effects of mindfulness meditation on anxiety levels; 3) To determine self-reported adherence rates following an eight-week small group instructional course on mindfulness meditation, and 4) To determine the effects of mindfulness meditation on global sense of coherence levels in persons with COPD. The National Center for Complementary and Alternative Medicine identifies meditation as a form of CAM that focuses on the interaction among the brain, body, mind and behavior that is already practiced by 8% of persons who participate in CAM therapy. Meditation is rated a special priority research area by NCCAM.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: mindfulness meditation class Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. |
Behavioral: Mindfulness meditation
Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned.
|
No Intervention: wait list Subjects assigned to the control group will continue with medical treatment as usual and be allowed to attend the mindfulness meditation class after week eight. |
Outcome Measures
Primary Outcome Measures
- Changes in Respiratory Rate [baseline and at week eight]
Breathing patterns will be measured at baseline using inductive plethysmography at baseline and at week eight. During that eight week time period the treatment group will have been exposed to a once a week mindfulness meditation class and the control group will have been exposed to health care as usual.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Any stage of Chronic Obstructive Pulmonary Disease
-
Able to read and write English
Exclusion Criteria:
-
Severe mental disability
-
Inability to attend
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Michigan | Ann Arbor | Michigan | United States | 48109 |
Sponsors and Collaborators
- University of Michigan
Investigators
- Principal Investigator: Roxane R Chan, RN, PhD (c), University of Michigan
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- um-nursing-meditation
Study Results
Participant Flow
Recruitment Details | Change was made to original number of participants due to human error. 51 persons were approached regarding possible enrollment. |
---|---|
Pre-assignment Detail |
Arm/Group Title | Mindfulness Meditation Class | Wait List |
---|---|---|
Arm/Group Description | Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. Mindfulness meditation: Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. | Subjects assigned to the control group will continue with medical treatment as usual and be allowed to attend the mindfulness meditation class after week eight. |
Period Title: Overall Study | ||
STARTED | 19 | 22 |
COMPLETED | 16 | 22 |
NOT COMPLETED | 3 | 0 |
Baseline Characteristics
Arm/Group Title | Mindfulness Meditation Class | Wait List | Total |
---|---|---|---|
Arm/Group Description | Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. Mindfulness meditation: Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. | Subjects assigned to the control group will continue with medical treatment as usual and be allowed to attend the mindfulness meditation class after week eight. | Total of all reporting groups |
Overall Participants | 19 | 22 | 41 |
Age (Count of Participants) | |||
<=18 years |
0
0%
|
0
0%
|
0
0%
|
Between 18 and 65 years |
3
15.8%
|
1
4.5%
|
4
9.8%
|
>=65 years |
16
84.2%
|
21
95.5%
|
37
90.2%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
70.3
(5.2)
|
68.7
(4.8)
|
69.5
(7.9)
|
Sex: Female, Male (Count of Participants) | |||
Female |
13
68.4%
|
14
63.6%
|
27
65.9%
|
Male |
6
31.6%
|
8
36.4%
|
14
34.1%
|
Region of Enrollment (Count of Participants) | |||
United States |
19
100%
|
22
100%
|
41
100%
|
Outcome Measures
Title | Changes in Respiratory Rate |
---|---|
Description | Breathing patterns will be measured at baseline using inductive plethysmography at baseline and at week eight. During that eight week time period the treatment group will have been exposed to a once a week mindfulness meditation class and the control group will have been exposed to health care as usual. |
Time Frame | baseline and at week eight |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Mindfulness Meditation Class | Wait List |
---|---|---|
Arm/Group Description | Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. Mindfulness meditation: Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. | Subjects assigned to the control group will continue with medical treatment as usual and be allowed to attend the mindfulness meditation class after week eight. |
Measure Participants | 16 | 22 |
Baseline |
15.93
(2.82)
|
17.18
(6.44)
|
Follow-up |
21.31
(3.05)
|
18.73
(4.31)
|
Statistical Analysis 1
Statistical Analysis Overview | Comparison Group Selection | Mindfulness Meditation Class, Wait List |
---|---|---|
Comments | This is a calculated P value comparing two groups at baseline and follow-up | |
Type of Statistical Test | Superiority or Other | |
Comments | ||
Statistical Test of Hypothesis | p-Value | 0.05 |
Comments | This is a calculated P value and was not adjusted for multiple comparisons. | |
Method | ANOVA | |
Comments |
Adverse Events
Time Frame | Eight weeks | |||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | Mindfulness Meditation Class | Wait List | ||
Arm/Group Description | Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. Mindfulness meditation: Group class on mindfulness meditation. One hour weekly class led by nurse expert on meditation that includes mindfulness skills, body awareness skills and emotional awareness skills. Homework is assigned. | Subjects assigned to the control group will continue with medical treatment as usual and be allowed to attend the mindfulness meditation class after week eight. | ||
All Cause Mortality |
||||
Mindfulness Meditation Class | Wait List | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/19 (0%) | 0/22 (0%) | ||
Serious Adverse Events |
||||
Mindfulness Meditation Class | Wait List | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/19 (0%) | 0/22 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
Mindfulness Meditation Class | Wait List | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/19 (0%) | 0/22 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Roxane Raffin Chan |
---|---|
Organization | University of Michigan |
Phone | 7344780170 ext 734 |
roxchan@comcast.net |
- um-nursing-meditation